- Books
- ISBN: 9780128008850
Edition
ISBN: 0128008857 /
ISBN-13: 9780128008850
- Book Details
- Seller
-
-
|
|
- Details:
- ISBN:
0128008857
- ISBN-13:
9780128008850
- Publisher:
Elsevier
- Published:
2015
- Language:
English
- Alibris ID:
17001496563
|
- Shipping Options:
- Standard Shipping: $4.71
Choose your shipping method in Checkout. Costs may vary based on destination.
|
- Seller's Description:
- Very good. Prev. owner's markings at front, otherwise clean and tight. No dust jacket, as issued.
|
|
Hide Details ▴ |
-
Hardcover,
New
Personalized Immunosuppression in Transplantation: Role of Biomarker Monitoring and Therapeutic Drug Monitoring
by Oellerich, Michael (Editor), and Dasgupta, Amitava, Ph.D (Editor)
2015, Elsevier Science Publishing Co Inc
ISBN-13:
9780128008850
See Item Details ▾
|
Booksplease
HIGH
Southport,
MERSEYSIDE,
UNITED KINGDOM
|
$100.52
|
|
- Edition:
- 2015, Elsevier Science Publishing Co Inc
-
Hardcover,
New
- Available Copies: 5
|
- Details:
- ISBN:
0128008857
- ISBN-13:
9780128008850
- Publisher:
Elsevier Science Publishing Co Inc
- Published:
2015
- Language:
English
- Alibris ID:
17950663026
|
- Shipping Options:
- Standard Shipping: $4.71
Choose your shipping method in Checkout. Costs may vary based on destination.
|
- Seller's Description:
- New. Intended for professional and scholarly audience.
|
|
Hide Details ▴ |
-
Hardcover,
Good
Personalized Immunosuppression in Transplantation: Role of Biomarker Monitoring and Therapeutic Drug Monitoring
2015, Elsevier
ISBN-13:
9780128008850
See Item Details ▾
|
Bonita
HIGH
Newport Coast,
CA,
USA
|
$106.78
|
|
- Edition:
- 2015, Elsevier
-
Hardcover,
Good
|
- Details:
- ISBN:
0128008857
- ISBN-13:
9780128008850
- Publisher:
Elsevier
- Published:
2015
- Language:
English
- Alibris ID:
18023585873
|
- Shipping Options:
- Standard Shipping: $4.71
Choose your shipping method in Checkout. Costs may vary based on destination.
|
- Seller's Description:
- Good. Access codes and supplements are not guaranteed with used items. May be an ex-library book.
|
|
Hide Details ▴ |
|
|
|
|